Previous studies reported TTC21A was associated with the prognosis and immune infiltrating level in lung adenocarcinoma (LUAD) and colorectal cancer (Wang et al., 2020; Li et al., 2022). The gene discussed is TTC21A; the disease is lung adenocarcinoma.